Evolution and global dissemination of macrolide-resistant group A streptococci.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMC 1563541)

Published in Antimicrob Agents Chemother on September 01, 2006

Authors

D Ashley Robinson1, Joyce A Sutcliffe, Wezenet Tewodros, Anand Manoharan, Debra E Bessen

Author Affiliations

1: Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA.

Articles citing this

Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance. FEMS Microbiol Rev (2011) 1.66

A decade of molecular pathogenomic analysis of group A Streptococcus. J Clin Invest (2009) 1.30

Population genetics and linkage analysis of loci within the FCT region of Streptococcus pyogenes. J Bacteriol (2006) 1.28

Population biology of the human restricted pathogen, Streptococcus pyogenes. Infect Genet Evol (2009) 1.27

Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States. J Clin Microbiol (2009) 1.20

M.SpyI, a DNA methyltransferase encoded on a mefA chimeric element, modifies the genome of Streptococcus pyogenes. J Bacteriol (2006) 1.04

Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains. Antimicrob Agents Chemother (2008) 1.00

Molecular epidemiology and genomics of group A Streptococcus. Infect Genet Evol (2014) 1.00

New genetic element carrying the erythromycin resistance determinant erm(TR) in Streptococcus pneumoniae. Antimicrob Agents Chemother (2007) 0.97

Tetracycline resistance in group a streptococci: emergence on a global scale and influence on multiple-drug resistance. Antimicrob Agents Chemother (2007) 0.90

Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development. Clin Vaccine Immunol (2014) 0.88

Lysogenic transfer of mef(A) and tet(O) genes carried by Phim46.1 among group A streptococci. Antimicrob Agents Chemother (2010) 0.83

Epidemiological Study of Erythromycin-Resistant Streptococcus pyogenes From Korea and Japan by emm Genotyping and Multilocus Sequence Typing. Ann Lab Med (2016) 0.82

Identification of Streptococcus uberis multilocus sequence types highly associated with mastitis. Appl Environ Microbiol (2007) 0.81

Identification of Quorum-Sensing Inhibitors Disrupting Signaling between Rgg and Short Hydrophobic Peptides in Streptococci. MBio (2015) 0.80

Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii. J Clin Microbiol (2010) 0.79

Molecular Basis for Erythromycin Resistance in Group A Streptococcus Isolated From Skin and Soft Tissue Infections. J Clin Diagn Res (2015) 0.77

Novel perspectives on the role of the human microbiota in regenerative medicine and surgery. Biomed Rep (2016) 0.75

Superiority of D-zone Testing Method over Standard Method to detect Rnducible Resistance in Gram Positive Bacteria: a Prospective Surveillance from a Teaching Hospital in Saudi Arabia. Int J Health Sci (Qassim) (2008) 0.75

Articles cited by this

Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J Clin Microbiol (1988) 28.11

eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol (2004) 17.92

Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother (1996) 10.56

The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med (1997) 9.63

Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother (1996) 8.65

Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A (2001) 7.90

Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother (1991) 7.18

Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J Clin Microbiol (2001) 6.26

Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2003) 5.29

Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect Immun (2001) 5.27

Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics (2000) 4.98

A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother (1998) 3.97

Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N Engl J Med (2002) 3.96

Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group a streptococci from children with acute pharyngitis. Pediatrics (2001) 3.68

The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin. J Clin Pathol (1959) 2.99

Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet (1999) 2.61

Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother (2001) 2.42

Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae. Antimicrob Agents Chemother (2000) 2.21

A biological price of antibiotic resistance: major changes in the peptidoglycan structure of penicillin-resistant pneumococci. Proc Natl Acad Sci U S A (1990) 2.18

Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet (2001) 2.15

Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin Infect Dis (2005) 2.13

Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. J Antimicrob Chemother (2002) 2.08

Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob Agents Chemother (1999) 2.01

The impact of homologous recombination on the generation of diversity in bacteria. J Theor Biol (2005) 1.99

Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures. J Bacteriol (2004) 1.95

Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance. J Infect Dis (2003) 1.90

Genomic localization of a T serotype locus to a recombinatorial zone encoding extracellular matrix-binding proteins in Streptococcus pyogenes. Infect Immun (2002) 1.80

Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan. Am J Dis Child (1979) 1.71

Retracted Directional gene movement from human-pathogenic to commensal-like streptococci. Infect Immun (2001) 1.61

Structure and distribution of an unusual chimeric genetic element encoding macrolide resistance in phylogenetically diverse clones of group A Streptococcus. J Infect Dis (2003) 1.49

Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations. J Antimicrob Chemother (2002) 1.42

The novel conjugative transposon tn1207.3 carries the macrolide efflux gene mef(A) in Streptococcus pyogenes. Microb Drug Resist (2003) 1.41

Influence of recombination and niche separation on the population genetic structure of the pathogen Streptococcus pyogenes. Infect Immun (2002) 1.31

Decline of erythromycin resistance of group A streptococci in Japan. Pediatr Infect Dis J (1994) 1.28

Group A streptococci from a remote community have novel multilocus genotypes but share emm types and housekeeping alleles with isolates from worldwide sources. J Infect Dis (2004) 1.27

23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A-->G. Proc Natl Acad Sci U S A (2005) 1.24

Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan. J Clin Microbiol (2000) 1.16

Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis (1998) 1.16

Community-based surveillance in the united states of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons. Clin Infect Dis (2004) 1.15

Prophage association of mef(A) elements encoding efflux-mediated erythromycin resistance in Streptococcus pyogenes. J Antimicrob Chemother (2005) 1.10

A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. J Antimicrob Chemother (2004) 1.07

Clinical and molecular epidemiology of erythromycin-resistant beta-hemolytic lancefield group G streptococci causing bacteremia. J Clin Microbiol (2003) 1.07

mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway. J Antimicrob Chemother (2005) 1.07

Characterization of an erythromycin resistance (erm) plasmid in Streptococcus pyogenes. APMIS (1995) 1.05

Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001. Antimicrob Agents Chemother (2003) 1.04

Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J Clin Microbiol (2002) 1.02

Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany. Antimicrob Agents Chemother (2004) 1.01

Identity and prevalence of multilocus sequence typing-defined clones of group A streptococci within a hospital setting. J Clin Microbiol (2005) 0.89

Macrolide resistance in group A Streptococcus. Pediatr Infect Dis J (2002) 0.88

Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain. J Antimicrob Chemother (2003) 0.86

Streptococcal toxic shock syndrome by an iMLS resistant M type 77 Streptococcus pyogenes in the Netherlands. Scand J Infect Dis (2005) 0.84

Horizontal transfer of erythromycin resistance from Clostridium difficile to Butyrivibrio fibrisolvens. Antimicrob Agents Chemother (2005) 0.83

Streptococcus pyogenes isolates with high-level macrolide resistance and reduced susceptibility to telithromycin associated with 23S rRNA mutations. Antimicrob Agents Chemother (2006) 0.83

Articles by these authors

Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures. J Bacteriol (2004) 1.95

Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance. FEMS Microbiol Rev (2011) 1.66

Population structure of a hybrid clonal group of methicillin-resistant Staphylococcus aureus, ST239-MRSA-III. PLoS One (2010) 1.64

Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic. Antimicrob Agents Chemother (2012) 1.61

Natural selection and evolution of streptococcal virulence genes involved in tissue-specific adaptations. J Bacteriol (2004) 1.57

Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent. J Med Chem (2012) 1.48

The Nlrp3 inflammasome regulates acute graft-versus-host disease. J Exp Med (2013) 1.31

Influence of recombination and niche separation on the population genetic structure of the pathogen Streptococcus pyogenes. Infect Immun (2002) 1.31

Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase, but depends in part on Puma. Blood (2006) 1.31

Population genetics and linkage analysis of loci within the FCT region of Streptococcus pyogenes. J Bacteriol (2006) 1.28

Group A streptococci from a remote community have novel multilocus genotypes but share emm types and housekeeping alleles with isolates from worldwide sources. J Infect Dis (2004) 1.27

Roles of the plasminogen activator streptokinase and the plasminogen-associated M protein in an experimental model for streptococcal impetigo. Microbiology (2002) 1.21

Evolution of transcription regulatory genes is linked to niche specialization in the bacterial pathogen Streptococcus pyogenes. J Bacteriol (2005) 1.19

Role of streptococcal T antigens in superficial skin infection. J Bacteriol (2006) 1.18

Presence of streptococcal pyrogenic exotoxin A and C genes in human isolates of group G streptococci. FEMS Microbiol Lett (2003) 1.12

Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics (2004) 1.07

Phase 2, randomized, double-blind study of the efficacy and safety of two dose regimens of eravacycline versus ertapenem for adult community-acquired complicated intra-abdominal infections. Antimicrob Agents Chemother (2013) 1.07

Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with tourette syndrome: a preliminary study. Biol Psychiatry (2006) 1.03

Variation in Streptococcus pyogenes NAD+ glycohydrolase is associated with tissue tropism. J Bacteriol (2010) 1.03

Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany. Antimicrob Agents Chemother (2004) 1.01

Population genetics of Streptococcus dysgalactiae subspecies equisimilis reveals widely dispersed clones and extensive recombination. PLoS One (2010) 1.00

Role of Mga in group A streptococcal infection at the skin epithelium. Microb Pathog (2008) 1.00

Pharmacy and self-report adherence measures to predict virological outcomes for patients on free antiretroviral therapy in Tamil Nadu, India. AIDS Behav (2013) 0.95

Heterogeneity in the polarity of Nra regulatory effects on streptococcal pilus gene transcription and virulence. Infect Immun (2008) 0.94

Streptococcal upper respiratory tract infections and psychosocial stress predict future tic and obsessive-compulsive symptom severity in children and adolescents with Tourette syndrome and obsessive-compulsive disorder. Biol Psychiatry (2009) 0.92

Complement factor H allotype 402H is associated with increased C3b opsonization and phagocytosis of Streptococcus pyogenes. Mol Microbiol (2008) 0.92

Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant. Clin Vaccine Immunol (2011) 0.91

Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy. J Med Chem (2012) 0.90

Tetracycline resistance in group a streptococci: emergence on a global scale and influence on multiple-drug resistance. Antimicrob Agents Chemother (2007) 0.90

8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents. J Med Chem (2011) 0.89

Impact of orthologous gene replacement on the circuitry governing pilus gene transcription in streptococci. PLoS One (2008) 0.87

Fecal carriage rates of extended-spectrum β-lactamase-producing Escherichia coli among antibiotic naive healthy human volunteers. Microb Drug Resist (2014) 0.86

The Seventh International Conference on the Genetics of Streptococci, Lactococci, and Enterococci. J Bacteriol (2006) 0.85

Macrolide-resistant pneumococcal endocarditis and epidural abscess that develop during erythromycin therapy. Clin Infect Dis (2003) 0.83

Detection of oxacillin-susceptible mecA-positive Staphylococcus aureus isolates by use of chromogenic medium MRSA ID. J Clin Microbiol (2012) 0.83

Multidrug-resistant Streptococcus pneumoniae from India. Lancet (2002) 0.81

A novel antibiotic CJ-17,572 from a fungus, Pezicula sp. J Antibiot (Tokyo) (2002) 0.79

Risk factors for upper respiratory infection in the first year of life in a birth cohort. Int J Pediatr Otorhinolaryngol (2012) 0.79

Susceptibility of tetracyclines to Tet(a) resistance is independent of interdomain loop sequence. Antimicrob Agents Chemother (2013) 0.78

Wiring the streptococcal network for alternative lifestyles. J Infect Dis (2010) 0.78

Detecting key structural features within highly recombined genes. PLoS Comput Biol (2007) 0.77

Targets for intervention to improve virological outcomes for patients receiving free antiretroviral therapy in Tamil Nadu, India. AIDS Care (2013) 0.77

Serovar prevalence of Leptospira in semirural India and the development of an IgM-based indirect ELISA. J Infect Dev Ctries (2017) 0.77

Development and characterization of a Pseudomonas aeruginosa in vitro coupled transcription-translation assay system for evaluation of translation inhibitors. J Microbiol Methods (2012) 0.75

Authors' response. Indian J Med Res (2013) 0.75

The search for a genetic divide between streptococcal pathogens and commensals. Clin Infect Dis (2007) 0.75

Synthesis and biological evaluation of 8-aminomethyltetracycline derivatives as novel antibacterial agents. J Med Chem (2013) 0.75

CJ-15,696 and its analogs, new furopyridine antibiotics from the fungus Cladobotryum varium: fermentation, isolation, structural elucidation, biotransformation and antibacterial activities. J Antibiot (Tokyo) (2002) 0.75